INSPIRE 8F DUAL PH.I.S.I.O.Recalls & reported problems
Sorin Group Italia Srl · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08033178112420), received between Jan 14, 2022 and Dec 6, 2022 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Medical Gas Supply Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Medical Gas Supply Problem1
- Unexpected Therapeutic Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 6, 2022Unexpected Therapeutic Results; Unexpected Therapeutic Results
SORIN GROUP ITALIA HAS RECEIVED A REPORT THAT, DURING AN EXTRA CORPOREAL CIRCULATION PROCEDURE, AT FIO2 OF 60% AND GAS FLOW AT 2.50 L/MIN, THE PAO2 RESULTED 50.6 MMHG. MEDICAL TEAM INCREASED THE FIO2 TO 100% AND THE PAO2 INCREASED TO 429 MMHG. MEDICAL TEAM DECREASED THE FIO2 BACK TO 60% AND THE PAO2 BECOME 57.9 MMHG. MEDICAL TEAM RE-INCREASED THE FIO2 TO 100% AND THE PAO2 INCREASED TO 427 MMHG. MEDICAL TEAM DECREASED THE FIO2 TO 80% AND PERFORMANCE OF THE INSPIRE OXYGENATOR DECLINED. DURING THE WARMING PHASE, EVEN THOUGH THE FIO2 WAS INCREASED TO 90%, THE PAO2 VALUES WERE POOR. THERE IS NO REPORT OF ANY PATIENT INJURY. ACCORDING TO INFORMATION, THE DAY BEFORE THE EVENT, THE OXYGENATOR HAD BEEN PRIMED AND RECIRCULATED FOR 3 HOURS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15922641 ↗MalfunctionJan 14, 2022Medical Gas Supply Problem; Medical Gas Supply Problem
LIVANOVA RECEIVED A REPORT THAT, AN OXYGENATOR REPLACEMENT DUE TO POOR OXYGENATION. THERE IS NO REPORT OF ANY PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13258091 ↗
Other OXYGENATOR, CARDIOPULMONARY BYPASS devices
- HLS Set BEQ-HLS 7050 USAMaquet Cardiopulmonary AG · Oxygenator, Cardiopulmonary Bypass3 recalls13 deaths90 reports
- Affinity Fusion® BB811Medtronic, Inc. · OXYGENATOR, CARDIOPULMONARY BYPASS2 recalls90 reports
- HLS Set BEQ-HLS 5050 USAMaquet Cardiopulmonary AG · Oxygenator, Cardiopulmonary Bypass3 recalls4 reports
- NA HLS Set Advanced 5.0, Small Adult, BIOLINE CoatingMaquet Cardiopulmonary AG · OXYGENATOR, CARDIOPULMONARY BYPASS3 recalls0 reports
- A.M.G. PMP Sterile A.M.G. Module PMP NO T.P. SterileEurosets Srl · Oxygenator, Cardiopulmonary Bypass2 deaths106 reports
- CAPIOX®FX CX*FX25RWTerumo Corporation · Oxygenator, Cardiopulmonary Bypass2 deaths102 reports
- CAPIOX®RX CX*RX25RWTerumo Corporation · Oxygenator, Cardiopulmonary Bypass1 death102 reports
- QUADROX-i HMO 50000-USA #SQUADROX-i Small Adult, no FilterMaquet Cardiopulmonary AG · OXYGENATOR, CARDIOPULMONARY BYPASS2 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page